tiprankstipranks
Oryzon Genomics (ES:ORY)
:ORY
Spanish Market

Oryzon Genomics SA (ORY) Technical Analysis

Compare
12 Followers

Summary of all the Indicators

Overall Consensus
Buy
12Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Oryzon Genomics’s (ORY) Moving Averages Convergence Divergence (MACD) indicator is 0.33, suggesting Oryzon Genomics is a Sell.
Oryzon Genomics’s (ORY) 20-Day exponential moving average is 2.30, while Oryzon Genomics’s (ORY) share price is €2.66, making it a Buy.
Oryzon Genomics’s (ORY) 50-Day exponential moving average is 1.93, while Oryzon Genomics’s (ORY) share price is €2.66, making it a Buy.

Oryzon Genomics SA (ORY) Pivot Points

Mar 06, 2025, 03:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.19
2.33
2.50
2.64
2.81
2.95
3.12
Fibonacci
2.33
2.45
2.52
2.64
2.76
2.83
2.95
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Oryzon Genomics SA (ORY) Moving Averages

Mar 06, 2025, 03:42 AM
Period
Simple
Exponential
MA5
2.72Sell
2.67Sell
MA10
2.71Sell
2.57Buy
MA20
2.16Buy
2.30Buy
MA50
1.74Buy
1.93Buy
MA100
1.69Buy
1.80Buy
MA200
1.77Buy
1.80Buy
Oryzon Genomics’s (ORY) 10-Day exponential moving average is 2.57, while Oryzon Genomics’s (ORY) share price is €2.66, making it a Buy.
Oryzon Genomics’s (ORY) 100-Day exponential moving average is 1.80, while Oryzon Genomics’s (ORY) share price is €2.66, making it a Buy.
Oryzon Genomics’s (ORY) stock price is €2.66 and Oryzon Genomics’s (ORY) 50-day simple moving average is 1.74, creating a Buy signal.
Oryzon Genomics’s (ORY) stock price is €2.66 and Oryzon Genomics’s (ORY) 100-day simple moving average is 1.69, creating a Buy signal.
Oryzon Genomics’s (ORY) stock price is €2.66 and Oryzon Genomics’s (ORY) 200-day simple moving average is 1.77, creating a Buy signal.

Oryzon Genomics SA (ORY) Technical Indicators

Mar 06, 2025, 03:42 AM
Name
Value
Implied Action
RSI (14)
59.55
Neutral
STOCH (9,6)
38.03
Neutral
STOCHRSI (14)
48.26
Neutral
MACD (12,26)
0.33
Sell
ADX (14)
43.64
Neutral
Williams %R
-52.93
Buy
CCI (14)
54.68
Neutral
ATR (14)
0.27
-
Ultimate Oscillator
46.97
Neutral
ROC
61.60
Buy
Oryzon Genomics’s (ORY) Relative Strength Index (RSI) is 59.55, creating a Neutral signal.
Oryzon Genomics’s (ORY) Trend Strength Indicator (ADX) is 43.64, creating a Neutral signal.
Oryzon Genomics’s (ORY) Commodity Channel Index (CCI) is 54.68, creating a Neutral signal.
Oryzon Genomics’s (ORY) Price Rate of Change (ROC) is 61.60, creating a Buy signal.

FAQ

Is ORY a Buy, Hold, or Sell?
Based on ORY’s technical indicators, ORY is a Buy.
    What is ORY’s RSI (14)?
    ORY’s RSI (14) is 59.55, which suggests ORY is a Neutral.
      What is ORY’s MACD?
      ORY’s MACD is 0.33, which suggests ORY is a Sell.
        What is ORY’s 5-day moving average?
        ORY’s 5-day moving average is 2.72, which suggests ORY is a Sell.
          What is ORY’s 20-day moving average?
          ORY 20-day moving average is 2.16, which suggests ORY is a Buy.
            What is ORY’s 50-day moving average?
            ORY’s 50-day moving average is 1.74, which suggests ORY is a Buy.
              What is ORY’s 200-day moving average?
              ORY’s 200-day moving average is 1.77, which suggests ORY is a Buy.
                What is ORY’s Williams % R (14)?
                ORY’s Williams % R (14) is -52.93, which suggests ORY is a Buy.
                  What is ORY’s CCI (14)?
                  ORY’s CCI (14) is 54.68, which suggests ORY is a Neutral.
                    What is the share price of Oryzon Genomics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis